9^th International Conference on Epilepsy & Treatment August 09-10, 2023 Paris, France

We welcome you and appreciate your participation at the 9^th International Conference on Epilepsy & Treatment  which is going to be held during August 09-10, 2023 Paris, France and it will be organized around the theme "Emerging Therapies For Improvement Of Epileptic Life". We cordially invite all the participants who are interested in sharing their knowledge and research in the area of Epilepsy & Neurology. Epilepsy 2023 deliberates thought provoking Keynote    lectures, Oral   Presentations, Poster   Presentations, Workshops,  Symposiums and Exhibition by the worldwide researchers.

Epilepsy 2023 covers various aspects of COVID-19 and Epilepsy, Epilepsy and Types of Seizures, Neurobiology of Epilepsy, Epileptogenesis, Epilepsy in Paediatrics, Epilepsy & Pregnancy, Epilepsy Surgery, Epilepsy Devices, Advanced Epilepsy Diagnosis Assessment, Seizure First Aid And Safety, SUDEP: Sudden Unexplained Death In Epilepsy, Cannabinoids in Treatment of Resistant Epilepsy, Metacognitive Beliefs in Epilepsy, Cognitive Disorders of Epilepsy, Prevention & Management of Epilepsy, Ketogenic Diet, Non-Surgical Treatment of Epilepsy, Herbal Treatments for Epilepsy, Homeopathic Treatment of Epilepsy, Immunomodulatory Treatments in Epilepsy, Epilepsy Therapeutics & Drug Therapy, Highly Marketed and Used Drugs of Epilepsy, Epilepsy Link with other Neurological Disorders, Epilepsy and Psychological Disorders, Epilepsy Case Reports.

Track 1:   COVID-19 AND EPILEPSY

The coronavirus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge we have faced since World War Two. Since its emergence in Asia late last year, the virus has spread to every continent except Antarctica. There is no evidence that having epilepsy alone makes people more likely to catch coronavirus or have more severe symptoms.

However, epilepsy is a very varied condition. Some people with epilepsy have other conditions alongside their epilepsy, which may put them at increased risk. Anyone with a compromised immune system or on-going medical challenges may have a higher risk of complications. The US Centers for Disease Control and Prevention (CDC) has included epilepsy on a list of conditions that may increase the risk of serious COVID-19 infection, likely because it is a chronic neurological condition. The UK has included people with chronic neurological conditions (without specifying epilepsy) as an “at risk” group.

Sub Track:

• COVID-19
• Epileptic Seizures
• Epilepsy Management
• Seizure Control

Relevant Conferences: Epilepsy Conferences | Neurological Disorder conferences | Seizures Conferences | Epilepsy conferences 2023 | Epilepsy Treatment 2023 | Epilepsy Research Conferences | Neurology Conferences | Neuroscience Conferences | Epilepsy Surgery Conferences | Epilepsy Treatment Conference | Epilepsy Congress | Neurology Conferences | Seizure Conferences

8^th International Conference on Epilepsy & Treatment, July 18-19, 2022 Amsterdam, Netherlands ; 9^th World congress on Addictive Disorders & Addiction Therapy, September 06-07, 2022 Berlin, Germany; 7^th World congress on Parkinsons & Huntington Disease, September 06-07, 2022 Berlin, Germany; 26th International Conference on Neurology & Neurophysiology, April 04-05, 2022 Berlin, Germany; 35^th European Neurology Congress, June 14-15, 2022 London, UK.

Track 2:  EPILEPSY AND TYPES OF SEIZURES

Epilepsy is a chronic non communicable and Neurological disorder of the brain that affects people of all ages. Epilepsy occurs when brain activity becomes abnormal, causing seizures. Seizures can affect any process your brain coordinates. Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.

Sub Tracks:

• Generalized seizures
• Absence seizures
• Tonic-clonic seizures
• Focal seizures

Track 3: NEUROBIOLOGY OF EPILEPSY

Epilepsy is a chronic disorder with diverse clinical characteristics that preclude a singular mechanism a neurological disorder marked by sudden recurrent episodes of seizures. A seizure occurs when part of the brain receives a burst of abnormal electrical signals that temporarily interrupts normal electrical brain function. It is one of the most common disorders of the nervous system and affects people of all ages, races, and ethnic background. The fact that multiple mechanisms exist is not surprising given the varied ways the normal nervous system controls this balance. In contrast, understanding seizures in brain of an individual with epilepsy is more difficult because seizures are typically superimposed on an altered nervous system.

Sub Tracks: 

• Birth trauma
• Alcohol or Drugs
• Brain tumor
• Neurological problems
• Alzheimer's disease
• Stroke.

Track 4: EPILEPTOGENESIS

Epileptogenesis is the chronic process by which a normal brain develops epilepsy. Epilepsy is a chronic condition in which seizures occur. These changes to the brain occasionally cause neurons to fire in a hyper-synchronous manner, known as a seizure. Epileptogenesis can be triggered by genetic or acquired factors, and that can continue long after epilepsy diagnosis.

Sub Tracks:

• Traumatic brain injury (TBI)
• Stroke
• Cerebral Tumour
• Intracranial Hemorrhage
• Status epilepticus
• Seizures
• Epilepsy

Track 5: EPILEPSY IN PEDIATRICS

Epilepsy can begin at any time of life, but it is most commonly diagnosed in children and people over the age of 65. More than half of children with epilepsy will outgrow their seizures as they mature, while others may have seizures that continue into adulthood. Although epilepsy varies from person to person, children with epilepsy generally have seizures that respond well to medication. Epilepsy affects around 1 in every 200 children and young people under 18 Children having idiopathic. About two-thirds of all children with epilepsy outgrow their seizures by the time they are teenagers. However, it is important for parents to help their child maintain a healthy lifestyle and ensure regular medical visits.

Sub Tracks:

• Febrile convulsions
• Childhood absence epilepsy
• Epilepsy in gender & age
• Seizures in childhood
• Attention Deficit Hyperactivity Disorder (ADHD)

Relevant Conferences: Epilepsy Conferences | Neurological Disorder conferences | Seizures Conferences | Epilepsy conferences 2023 | Epilepsy Treatment 2023 | Epilepsy Research Conferences | Neurology Conferences | Neuroscience Conferences | Epilepsy Surgery Conferences | Epilepsy Treatment Conference | Epilepsy Congress | Neurology Conferences | Seizure Conferences

Track 6: EPILEPSY & PREGNANCY

Women with epilepsy have a number of unique concerns during pregnancy. Pregnant women with epilepsy constitute 0.5% of all pregnancies. Some antiepileptic drugs considered safe to the foetus may be associated with increased risk of seizures and maternal mortality. Factors such as epilepsy, anticonvulsant-induced teratogenicity, patient's genetic predisposition and the severity of convulsive disorder may attribute to adverse pregnancy outcome for the children of women with epilepsy.

Sub Tracks:

• Epilepsy during Pregnancy
• Anti-epileptic drugs
• Pregnancy and Motherhood
• Brain infections

8th International Conference on Epilepsy & Treatment, July 18-19, 2022 Amsterdam, Netherlands; 9^th World congress on Addictive Disorders & Addiction Therapy, September 06-07, 2022 Berlin, Germany; 7^th World congress on Parkinsons & Huntington Disease, September 06-07, 2022 Berlin, Germany; 26^th International Conference on Neurology & Neurophysiology, April 04-05, 2022 Berlin, Germany; 35^th European Neurology Congress, June 14-15, 2022 London, UK.

Track 7: EPILEPSY SURGERY

Medications can control seizures in most people with epilepsy, but they don’t work for everyone. About 30% of people taking the drugs can’t tolerate the side effects. A person's type of seizures and where they begin in the brain are key to deciding what kind of surgery may help. Surgery has three main goals, they are Remove the area of the brain that causes seizures, Disrupt the nerve pathways that seizure impulses take through your brain, Implant a device to treat epilepsy. An operation on the brain can control seizures and improve your quality of life.

Sub Tracks:

• Focal Resection
• Lobectomy
• Multiple Subpial Transection
• Hemispherectomy
• Corpus callosotomy
• Stereotactic Radiosurgery
• Neurostimulation Device Implantations

Related Associations and Societies: Epilepsy Association of Austria (EDO), Epilepsy Foundation (USA), The Swedish Epilepsy Association, The Italian League Against Epilepsy, Epilepsy Association (Finland), Danish Epilepsy Association, Epilepse-France, Indian Epilepsy Association, Japan Epilepsy Association, Singapore Epilepsy Foundation, Epi-Switzerland, Epilepsy Support and Information Centre (Saudi Arabia), Epi- Apfape (EPI), Caritas Malta Epilepsy Association, Norwegian Epilepsy Association, Iranian Epilepsy Association, German Epilepsy Association.

Track 8: EPILEPSY DEVICES

Seizure medicines do not control seizures or can cause bothersome side effects in at least 3 out of 10 people with epilepsy. Seizure alert devices are useful in letting family members know if a seizure is occurring, especially parents of young children. The devices can notify nearby family or caregivers when a seizure occurs through alarms, phone calls or text alerts, depending on the device. They may also be able to give rescue medications or call for an ambulance if the seizure lasts too long or the person has repeated seizures.

Sub Tracks:

• Vagus Nerve Stimulation
• Seizure Alarms
• Medic Alert bracelet
• Anti-suffocation pillows
• Mattress devices
• Cameras
• Smart watches

Track 9: ADVANCED EPILEPSY DIAGNOSIS ASSESSMENT

Doctors have developed when an individual experience a seizure for the first time doctors advices him for EEG and observes for abnormality in the of EEG these tests differentiate patient from epileptic to non- epileptic. Research suggests that patients are only suggested to medicate for epilepsy only after their occurrence of second seizure. Many non-epileptic patients experience an unusual brain activity so; it is advised to record EEG while sleeping is preferable. Brain scans like CT- SCAN are used.

Sub Tracks:

• EEG
• CT SCAN
• Positron emission tomography
• Magnetic resonance imaging
• Single photon emission tomography
• Magneto encephalogram
• MRS
• Medical history
• Blood tests

Track 10: SEIZURE FIRST AID AND SAFETY

Epilepsy is a common condition of the brain in which a person has a tendency to have recurrent unprovoked seizures. About 1 out of 10 people may have a seizure during his or her lifetime. Safety precautions should be sensible and relevant to the person, with a balance between risk and restrictions. That means seizures are common, and one day you might need to help someone during or after a seizure. First aid for seizures is aimed at keeping the person safe until the seizure stops on its own.

Sub Tracks:

• Epileptic seizure first aid
• Sudden unexpected death in epilepsy (SUDEP)
• Seizure emergencies
• Epilepsy and General Hazards
• Epilepsy and Safety

Track 11: SUDEP: SUDDEN UNEXPLAINED DEATH IN EPILEPSY

Sudden Unexpected Death in Epilepsy (SUDEP) is a fatal complication of epilepsy. SUDEP accounts for 7–17% of deaths among people with epilepsy. This is the leading cause of death in people with uncontrolled seizures. Patients with uncontrolled seizures are at greatest risk for SUDEP, and experiencing tonic-clonic seizures, taking multiple antiepileptic drugs and having coexisting neurologic disease further increase the risk.

Sub Tracks:

• Uncontrolled or Frequent Seizures
• Generalized Convulsive Seizures
• Epilepsy in Childhood
• Missed doses of medicine
• Alcohol or Drugs

Track 12: METACOGNITIVE BELIEFS IN EPILEPSY

Emotional distress is common in people with epilepsy (PWE) for which efficacious interventions are required. Developing evidence-based treatments should be based on testable models of the psychological mechanisms maintaining Psychopathology. The Self-Regulatory Executive Function (S-REF) model proposes that maladaptive Metacognitive beliefs and processes are central to the development and maintenance of emotional distress. Although preliminary support exists for the role of metacognitive beliefs in emotional distress in PWE, their role has yet to be tested when controlling for the contribution made by illness perceptions.

Sub Tracks:

• Anxiety
• Depression

Track 13: COGNITIVE DISORDERS OF EPILEPSY

Cognitive disorders are common in patients with epilepsy. Their aetiology is multifactorial, being affected by the type and location of the epileptogenic lesion, Epileptic syndrome, type of seizures, and age of onset, frequency and severity. Timely diagnosis and treatment can help to reduce their impact on the patient's quality of life.

Sub Tracks:

• Temporary confusion
• A Staring Spell
• Uncontrollable jerking movements of the arms and legs
• Loss of consciousness or awareness

Track 14: PREVENTION & MANAGEMENT OF EPILEPSY

Preventing seizures and other problems must be part of seizure management. This means working together with your health care team to control seizures as best as possible. Maintaining Ketogenic diet, regular exercise can reduce the risk of Epilepsy, get plenty of sleep during nights and avoid using drugs and alcohol, taking seizure medicines regularly as problems taking medicines is one of the biggest risks for uncontrolled seizures. Epilepsy due to medication can be subsided by discontinuing the medicines, controlling stress, anxiety & other emotional issues can reduce the risk of Epilepsy. People can also adjust their lifestyle and environment to reduce the chance of seizures.

Sub Tracks:

• Anticonvulsants
• Anti-Epileptogenic Drugs
• Anti-Seizure Medications
• Vagus Nerve Stimulation
• Ketogenic Diet

Track 15: KETOGENIC DIET

The Ketogenic Diet (KD) is a modality of treatment used since the 1920s as a treatment for intractable epilepsy. The Ketogenic diet is a special high-fat, low-carbohydrate diet that helps to control seizures in some people with epilepsy. It is usually used in children with seizures that do not respond to medications. Evidence shows that KD and its variants are a good alternative for non-surgical pharmacoresistant patients with epilepsy of any age.

Sub Tracks:

• Classic Ketogenic Diet
• Medium chain triglyceride (MCT) diet
• Ketone Bodies: Anticonvulsant Effects
• Low Glycaemic Index Treatment (LGIT)

Track 16: NON-SURGICAL TREATMENT OF EPILEPSY

Epilepsy treatment has been applied to treat patients with intractable epilepsy for decades that are not controlled by neither antiepileptic drugs (AEDs) nor surgical candidates. If Antiepileptic drugs aren't controlling your seizures and brain surgery isn't suitable for you, there are other procedures that could help to control Epileptic Seizures.

Sub Tracks:

• Laser ablation
• SEEG
• Neuromodulation Therapy
• Vagal Nerve or Deep Brain Stimulation

Track 17:  HERBAL TREATMENTS FOR EPILEPSY

Before modern seizure medicines were developed, people with epilepsy and their doctors looked for a remedy in various herbs and combinations of herbs. Good news is, there are some natural remedies for seizures. Before advanced seizure medications were even discovered, doctors used herbs to treat this condition. Herbs for seizures are still used today because of their impressive effectiveness.

Sub Tracks:

• Burning bush
• Lily of the valley
• Hydrocotyle
• Groundsel
• Mugwort

Relevant Conferences: Epilepsy Conferences | Neurological Disorder conferences | Seizures Conferences | Epilepsy conferences 2022 | Epilepsy Treatment 2022 | Epilepsy Research Conferences | Neurology Conferences | Neuroscience Conferences | Epilepsy Surgery Conferences | Epilepsy Treatment Conference | Epilepsy Congress | Neurology Conferences | Seizure Conferences

Track 18: HOMEOPATHIC TREATMENT OF EPILEPSY

Epilepsy can be treated in a number of ways. One of the most preferred forms of treatment is Homeopathy. Homeopathy addresses both the physical symptoms of the disease and the underlying factors triggering it. Another big advantage of homeopathic treatment is that it has negligible side effects.

Sub Tracks:

• Cicuta
• Artemisia Vulgaris
• Cuprum Met
• Bufo Rana
• Hyoscyamus

8th International Conference on Epilepsy & Treatment, July 18-19, 2022 Amsterdam, Netherlands; 9^th World congress on Addictive Disorders & Addiction Therapy, September 06-07, 2022 Berlin, Germany; 7^th World congress on Parkinsons & Huntington Disease, September 06-07, 2022 Berlin, Germany; 26th International Conference on Neurology & Neurophysiology, April 04-05, 2022 Berlin, Germany; 35^th European Neurology Congress, June 14-15, 2022 London, UK.

Track 19:  IMMUNOMODULATORY TREATMENTS IN EPILEPSY

The role of Immunity and Inflammation appears to be an integral part of the pathogenic processes associated with some seizures, particularly with refractory epilepsy. Prompt treatment with Immunotherapy may lead to better outcomes. Immune treatment options for treatment of epilepsy include therapies such as corticosteroids, Immunoglobulin’s, Plasmapheresis, or steroid-sparing drugs such as azathioprine.

Sub Tracks:

• Intravenous immunoglobulin therapy
• Corticosteroids
• Immunoglobulins
• Plasmapheresis
• Azathioprine

Related Associations and Societies: Epilepsy Association of Austria (EDÖ), Epilepsy Foundation (USA), The Swedish Epilepsy Association, The Italian League Against Epilepsy, Epilepsy Association (Finland), Danish Epilepsy Association, Epilepse-France, Indian Epilepsy Association, Japan Epilepsy Association, Singapore Epilepsy Foundation, Epi-Switzerland, Epilepsy Support and Information Centre (Saudi Arabia), Epi- Apfape (EPI), Caritas Malta Epilepsy Association, Norwegian Epilepsy Association, Iranian Epilepsy Association, German Epilepsy Association.

Track 20: EPILEPSY THERAPEUTICS & DRUG THERAPY

Zonisamide Ethosuximide is now available as rectal gel so that can be applied by family members for prolonged seizures. Drug combination sometimes lead to adverse effects like fatigue and loss of appetite so, combinations are often replaced by Monotherapy, unless monotherapy achieves desired results. When medication doesn’t achieve the required targets doctor can sometimes suggest for surgery 64% cases showed seizure free cases who undergone surgery.

Sub Tracks:

• Valproic acid
• Carbamazepine
• Lamotrigine
• Levetiracetam

Track 21:  HIGHLY MARKETED AND USED DRUGS FOR EPILEPSY

The global market for Antiepileptic drugs is driven by advancement in drugs modification. Over the past several periods, the number of available Antiepileptic drugs has more than doubled. Many of the presently available Antiepileptic drugs have basics pharmacokinetics and more small effects on liver metabolism that converts into a lower rate of side effects, The antiepileptic drug market is threatened by generic competition, which has risen dramatically in the face of patent expirations among various major branded Antiepileptic drugs. These are the major restraints for the Global antiepileptic drugs market.

Sub Tracks:

• Carbamazepine
• Phenobarbital
• Phenytoin
• Primidone
• Topiramate

Relevant Conferences: Epilepsy Conferences | Neurological Disorder conferences | Seizures Conferences | Epilepsy conferences 2022 | Epilepsy Treatment 2022 | Epilepsy Research Conferences | Neurology Conferences | Neuroscience Conferences | Epilepsy Surgery Conferences | Epilepsy Treatment Conference | Epilepsy Congress | Neurology Conferences | Seizure Conferences

8th International Conference on Epilepsy & Treatment, July 18-19, 2022 Amsterdam, Netherlands; 9^th World congress on Addictive Disorders & Addiction Therapy, September 06-07, 2022 Berlin, Germany; 7^th World congress on Parkinsons & Huntington Disease, September 06-07, 2022 Berlin, Germany; 26th International Conference on Neurology & Neurophysiology, April 04-05, 2022 Berlin, Germany; 35^th European Neurology Congress, June 14-15, 2022 London, UK.

Related Associations and Societies: Epilepsy Association of Austria (EDO), Epilepsy Foundation (USA), The Swedish Epilepsy Association, The Italian League Against Epilepsy, Epilepsy Association (Finland), Danish Epilepsy Association, Epilepse-France, Indian Epilepsy Association, Japan Epilepsy Association, Singapore Epilepsy Foundation, Epi-Switzerland, Epilepsy Support and Information Centre (Saudi Arabia), Epi- Apfape (EPI), Caritas Malta Epilepsy Association, Norwegian Epilepsy Association, Iranian Epilepsy Association, German Epilepsy Association.

Track 22: EPILEPSY LINK WITH NEUROLOGICAL DISORDERS

The epilepsies have many possible causes, but for up to half of people with epilepsy a cause is not known. In other cases, the epilepsies are clearly linked to genetic factors, developmental brain abnormalities, infection, traumatic brain injury, stroke, brain tumors, or other identifiable problems.

Sub Tracks:

• Epilepsy and Parkinson Disease
• Epilepsy and Alzheimers Disease
• Epilepsy and Dementia
• Epilepsy and Stroke
• Epilepsy and Autism
• Epilepsy and Brain Tumor
• Epilepsy and Schizophrenia

Track 23: EPILEPSY AND PSYCHOLOGICAL DISORDERS

Epilepsy is not a mental illness. In fact, the vast majority of people living with epilepsy have no cognitive or psychological problem. For the most part, psychological issues in epilepsy are limited to people with severe and uncontrolled epilepsy.

Sub Tracks:

• Epilepsy  Intellectual Disability
• Epilepsy and Depression
• Epilepsy and Cognitive Disorders
• Epilepsy and Anxiety
• Epilepsy and Behavioural Issues

• As an add on advantage the Speaker & Abstract pages created in Google on your profile under your name would get worldwide visibility
• Our robust online publicity attracts 20000+ users and 60000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences
• All the conference participants can earn up to 16-18 CME Credits by participating at our Epilepsy Conference scheduled at Amsterdam, Netherlands.
• To attain professional development we offer our participants a chance to earn up to 21 CPD Credits authorized by CPD Standards Office, UK by participating at our Epilepsy  Conferences.
•  All the conference participants will be awarded with IOCM Certification.
•  All the conference participants will have an unique opportunity to participate at One on One Meeting with Eminent Speakers
•  A Unique opportunity to hear what the global researchers are talking about at our Keynote sessions by world’s most eminent researchers in the field of  Neurology.
• Top Industries Representation of Industrial Leaders, where you get a great opportunity to meet and discuss with the Industrial Leaders in person
• Thought provoking Symposia’s
•  Workshops on Carrier Development
•  Preconference workshops in all major countries
•  Nominations for Best Poster Award
•  Outstanding Young Researcher Award
•  Group Registration benefits

Benefits of Participation | Speaker:

• Explore the best in Cutting edge Research
• Worldwide acknowledgment of Researcher’s profile
• Obtain professional development credits
• Your presence and talk will be recorded and hosted on YouTube and Vimeo which in turn will gain potential value to your research profile.
• Make Lasting connections at Networking and Social Events
• We provide unique convergence of Networking, Learning and Fun into a single package
• An opportunity to give One page advertisement in abstract book and flyers distribution which eventually gets 1 Million views and add great value to your research profile
• Learn beyond your field of interest, a change to know more about the new topics and research apart from your core subject

Benefit of Participation | Sponsor:

• Worlds No1 Platform to show case  Epilepsy  Products
• Exposure to the international atmosphere will increase the odds of getting new business
• Opportunity to showcase the new technology, new products of your company, and/or the service your industry to a broad international audience
• Attain with an exceptional format in showcasing the products and services and to gain the potential clients for the future business prospects
• Our Neurology Conference in the One and only location to reach the top customers

• Make new connections and fostering potential partnerships
• Increase your business by lead generation through our conference participants.
• Build a successful business takes a lot of time, effort and drive, so it’s always good to have a network of colleagues and associates to draw energy from people who share a similar drive and objective.
• Flip side of learning new things is relearning classic techniques. Neurology conferences create opportunities for greater focus and reflection that could help you take your business to the next level.
• Benchmarking key strategies for business and moving it forward
• Get answers to your business questions and challenges from credible individuals at our conference
• Exposure and Networking Opportunity with the various top decision makers of the respective organizations, will eventually grow your business in Global market
• Get to know more about your competitors are first-hand, learn more about their businesses, and discover their strengths and weaknesses, all of which can add to your business’s competitive edge.
• Encounter new vendors and suppliers for your business
• Real Benefits in New business - Many Organizations make deals and sign contracts at our Neurology Conference
• We offer you the Website visibility to more than 35K visitors in less than 6 months
• Promotional logo of your organisation at our conference banner, website and other proceedings, branding and marketing material
• Hosting session slots, poster awards, recognition in opening ceremony and complimentary registrations, exhibition/workshop booth, low-budget options.

Benefit of Association for Collaborators:        

• No one in the world have this huge visitors towards Neurology, these is the best platform to show case your society.

    Create long-lasting relationships with the peers

• Promotional content and Logo of your Association at our conference banner, website and other proceedings, branding and marketing material will increase your subscribers/Members number by 20 %.
• Our Website visibility to your Organization page can give a great impact for your association in the Global Market.
• Your representatives can network with key conference delegates to update their knowledge and understanding of your organization and services.
•  Details will be added to the conference press release where the details will be shared to < 100000 outlets
•  Details will be incorporated in all conference promotional materials which will be distributed to Hospitals, Universities, Society and Researchers

Benefits of Participation | Delegate:

• Helps to meet Experts & Influencers Face to Face.
• Opportunities to meet researchers and experts of same field and share new ideas
• Can help to know New Tips & Tactics
• Professional Development – Elevate your knowledge and Skills
• Conference attendance inspires, rejuvenates, and energizes delegates
• Your participation at our conference will be helpful for a new approach and ideology that can be utilized for the extending the outcome of Companies or Industries.
• Enjoy the alluring city environment where the conference is being held.
• Raise your profile by being well-known

Epilepsy can affect every one of us In Europe, at least 6 million people have epilepsy, and 15 million Europeans will have one seizure at some time in their lives. Nevertheless, in some countries of Europe, epilepsy is not recognized as a brain disorder and up to 40% of people with this condition may be untreated - the treatment gap. The global market for the industry was valued at $8.4 billion in 2017, and is forecasted to grow at a compound annual growth rate (CAGR) of 2.7% through 2023, when it will be worth an estimated $9.5 billion, according to the report Anti-Epileptic Drugs Market: Global Markets to 2023.

The Americas is the largest market for the epilepsy drugs due to the high prevalence of the disorder and the treatment options in the region, especially in the developed markets such as the US and Canada. Approximately 1% of the population in Canada has epilepsy, and 15,000 new cases are diagnosed each year.

North America is the largest market for anti-epileptic drugs manufacturing, accounting for 33.9% of the global market. It is followed by the Asia-Pacific region and Western Europe. Eastern Europe is expected to witness the fastest market growth, with CAGR of 5.4% through 2022. Second-generation anti-epileptic drugs accounted for the largest share of the market in 2017 at 44.3%. The highest growth is projected to come from third-generation antiepileptic drugs, which are forecasted to grow at a CAGR of 3.1%

The global epilepsy drugs market is primarily driven by the need of effective medications as the generic or branded drugs available in the market only provide symptomatic treatment. This has increased investment in the R&D of new drugs for epilepsy by companies such as Major players in the market include Pfizer Inc., UCB Biosciences Inc., GlaxoSmithKline PLC, Sanofi, Eisai Inc., Otsuka Pharmaceutical LTD., H. Lundbeck, Sumitomo Dainippon Pharma Co., Shire PLC., Marinus Pharmaceuticals, SAGE Therapeutics, H.Lundbeck, and CURx Pharmaceuticals

Importance and Scope

Epilepsy medications can prevent seizures. An epileptic seizure is caused by hyperactivity in the brain's nerve cells. Anti-epileptic drugs (AEDs) work by lowering this level of activity. Although AEDs do not cure the underlying causes of epilepsy, they can lower the risk of seizures. But they do not work in everyone. It is sometimes possible for people to stop taking medication if they haven't had a seizure for several years. The aim of drug treatment is to prevent epileptic seizures. If this is not possible, then the goal is to at least reduce the number of seizures.

Drug treatment helps to permanently prevent seizures in most people who have epilepsy. About 5 out of 10 people stop having seizures or have fewer seizures after taking the first drug they try. Overall, about 7 out of 10 people with epilepsy have no more seizures when they use medication. The 6 million people with epilepsy in Europe want to bring epilepsy “out of the shadows”.

Research related to epilepsy is remarkably broad and comprehensive, with programs in numerous university centers worldwide. On-going studies involve many scientific disciplines and areas of exploration.

Target Audience

• Doctors
• Neurologists
• Physicians
• Directors
• Pharmaceutical Industries
• Pharmacists
• Patients
• Students
• Professors
• Researchers in Epilepsy
• Epilepsy Foundations
• Epilepsy Diagnosis Centers

Related Companies

1. Pfizer Inc.
2. UCB Biosciences Inc.
3. GlaxoSmithKline PLC
4. Sanofi
5. Eisai Inc.
6. Otsuka Pharmaceutical LTD
7. H. Lundbeck
8. Sumitomo Dainippon Pharma Co.
9. Shire PLC.
10. Marinus Pharmaceuticals
11. SAGE Therapeutics
12. H.Lundbeck
13. CURx Pharmaceuticals
14. Novartis
15. Elan Corporation PLC

Related Associations and Societies

1. The International League Against Epilepsy (ILAE)
2. American Epilepsy Society (AES)
3. National Association of Epilepsy Centers (NAEC)
4. International Bureau for Epilepsy
5. European Concerted Action and research in Epilepsy (Eucare)
6. Epilepsy Foundation (of America)
7. The Japan Epilepsy Society
8. Epilepsy Action Australia
9. Epilepsy Foundation of Victoria
10. Associazione Italiana Contro l’Epilessia (AICE)
11. The Swedish Epilepsy Association
12. National Society for Epilepsy
13. Joint Epilepsy Council (JEC) for the UK and Ireland
14. Indian Epilepsy Association
15.  Rush Epilepsy Center

8^th International Conference on Epilepsy & Treatment was organized during August 01-02, 2022 Zurich, Switzerland, Webinar. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities, who made this conference fruitful and productive.

This conference was based on the theme “Seizures and Epilepsy: An Overview for Neuroscientists” which included the following scientific tracks: 

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Epilepsy 2022. We are glad to inform that all accepted abstracts for the conference have been published in International Journal of Tissue Science & Engineering: Open Access as a special issue.